[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"sacro-iliac-spondylosis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:sacro-iliac-spondylosis":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100631283","prp-injection-into-the-sacroiliac-joint-after-ipsilateral-tha-effects-on-early-recovery-and-function-sij-tha-randomized-trial-100631283",false,"NCT07498660","PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomized Trial)","Effect of Platelet-Rich Plasma Injection Into the Sacroiliac Joint After Ipsilateral Total Hip Arthroplasty on Early Rehabilitation and Patient Function: A Randomized Trial (SIJ-THA Trial)","Inclusion Criteria:\n\n* primary osteoarthritis of the hip;\n* qualification for elective total hip arthroplasty (THA);\n* age ≥45 years;\n* written informed consent;\n* ability to understand Polish.\n\nExclusion Criteria:\n\n* prior surgical treatment of the hip or sacroiliac joint;\n* malignancy;\n* developmental dysplasia of the hip;\n* rheumatologic diseases (rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis);\n* neurological or psychiatric disorders;\n* allergy to local anesthetics.","ALL","45 Years",{"count":19,"type":20},60,"ESTIMATED","INTERVENTIONAL",[23],"NA","The study is an interventional, randomized, open-label (non-blinded), placebo-controlled trial. Preoperatively, patients scheduled for primary total hip arthroplasty (THA) will undergo a clinical examination in the Orthopaedic Department. Clinical tests will be performed to confirm sacroiliac joint (SIJ) dysfunction on the operated side. In addition, low-dose computed tomography (CT) will be used to assess structural changes in the SIJ.\n\nAll patients will complete patient-reported outcome measures related to the hip joint, including the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the Harris Hip Score (HHS), as well as SIJ-related assessments, including the Oswestry Disability Index (ODI). Pain intensity will be assessed using the Visual Analogue Scale (VAS).\n\nFollowing THA, patients will be randomly allocated into two groups during their hospital stay. In the intervention group, platelet-rich plasma (PRP) will be injected into the sacroiliac joint, whereas the control group will receive an injection of normal saline. All injections will be performed in the operating theatre.\n\nAt discharge, patients will be scheduled for follow-up visits at 2, 6, and 12 weeks postoperatively. At each follow-up, patient-reported outcomes will be collected, including WOMAC and HHS for hip function, ODI for SIJ-related disability, and VAS for pain assessment of both the hip and sacroiliac joint.",[26,27,28,29],"Osteoarthitis","Sacro Iliac Joint Pain","Hip Arthroplasty, Total","Sacro-Iliac Spondylosis","NOT_YET_RECRUITING","2026-03-23",{"date":33,"type":34},"2026-03-27","ACTUAL",{"date":36,"type":20},"2026-04-01",{"date":38,"type":20},"2028-03-31",{"name":40,"class":41},"Medical University of Warsaw","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":16,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":4,"studyType":21,"phases":54,"briefSummary":56,"conditions":57,"keywords":4,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":42},"100536736","phase-4-particulate-vs-non-particulate-steroid-for-sacroiliac-joint-injection-100536736","NCT06268704","Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection","Particulate Versus Non-Particulate Corticosteroid in Sacroiliac Joint Injection: A Randomized Prospective Study","Inclusion Criteria:\n\n* Aged \\>18, capable of understanding and providing consent in English, capable of complying with the outcome instruments used, capable of attending all planned follow up visits\n* Unilateral low back\u002Fbuttocks pain of at least 2 weeks.\n* Patient reported 7 day average of numeric pain rating score (NPRS) low back\u002Fbuttocks pain of at least 5\u002F10 at baseline evaluation\n* Clinical diagnosis of sacroiliac joint pain as diagnosed by a board certified Physiatrist including history of low back\u002Fbuttocks pain and at least 2 positive physical exam findings (including positive fortin finger sign, pain with palpation of posterior superior iliac spine, positive FABER's test, positive Gaenslan's test, positive sacral distraction, positive thigh thrust, positive lateral compression, positive sacral thrust)\n* Patient consents to sacroiliac joint corticosteroid injection in a shared decision-making process with the treating physician.\n* 80% or more relief of index pain within first 5-15 minutes after injection\n\nExclusion Criteria:\n\n* Clinical suspicion of alternative process is greater than clinical suspicion of sacroiliac joint pain\n* Those receiving remuneration for their pain treatment (e.g., disability, worker's compensation).\n* Those involved in active litigation relevant to their pain.\n* Those unable to read English and complete the assessment instruments.\n* Those unable to attend follow up appointments\n* The patient is incarcerated.\n* History of prior sacroiliac joint fusion\n* Progressive lower extremity neurologic deficit (from active radiculopathy, unhealed radiculopathy, or neuromuscular disease)\n* Sacroiliac joint steroid injection within the prior 12 months\n* 2 Positive lumbar medial branch blocks within the past 12 months\n* Radiofrequency ablation of the lumbar spine within the past 12 months\n* Lumbar facet steroid injections within the past 12 months\n* Prior epidural steroid injection within the prior 3 months in any location within the spine.\n* Possible pregnancy or other reason that precludes the use of fluoroscopy.\n* Allergy to steroid, contrast media, or local anesthetics.\n* BMI\\>40.\n* Systemic inflammatory arthritis (e.g., rheumatoid arthritis, ankylosing spondylitis, lupus).\n* Active infection or treatment of infection with antibiotics within the past 7 days.\n* Medical conditions causing significant functional disability (e.g., stroke, decompensated ---COPD, decompensated heart failure)\n* Chronic widespread pain or somatoform disorder (e.g. fibromyalgia).\n* Addictive behavior, severe clinical depression, or psychotic features.","18 Years","99 Years",{"count":53,"type":20},230,[55],"PHASE4","This study will compare two different corticosteroids (dexamethasone and methylprednisolone) for use in sacroiliac joint injections to treat SI joint pain.",[58,29],"Sacroiliac Joint Dysfunction","RECRUITING","2025-11-04",{"date":62,"type":34},"2025-11-06",{"date":64,"type":34},"2024-03-27",{"date":66,"type":20},"2027-05-01",{"name":68,"class":41},"University of New Mexico"]